Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Murphy

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Molecular & General Genetics : MGG|May 20, 1997
The acetate regulatory gene facB of Aspergillus nidulans encodes a Zn(II)2Cys6 transcriptional activatorR B Todd, R L Murphy, H M Martin, et al.
Folia Morphologica|January 21, 2006
The results of compression forces applied to the isolated human calvariaR S Tubbs, R L Murphy, J B Golden, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Safety, pharmacokinetics, and efficacy of (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine with efavirenz and stavudine in antiretroviral-naïve human immunodeficiency virus-infected patientsC Herzmann, K Arastèh, R L Murphy, et al.
Archives of Environmental Health|October 1, 1972
Low exposure to asbestos. Gas exchange in ship pipe coverers and controlsR L Murphy, E A Gaensler, R A Redding, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1989
Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patientsP S Pegram, J P Phair, R McMahan, et al.
Chest|May 1, 1992
Concurrent bacterial lung infection in patients with AIDS, PCP, and respiratory failureW T Peruzzi, B A Shapiro, G A Noskin, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Predictors of outcome in AIDS patients receiving zidovudineJ P Steinberg, J B Spear, R L Murphy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1994
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044J R Black, J Feinberg, R L Murphy, et al.
HIV Medicine|May 26, 2010
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patientsS Lambert-Niclot, N Machouf, G Peytavin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 1999
Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3R B Pollard, D Peterson, D Hardy, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Molecular & General Genetics : MGG|May 20, 1997
The acetate regulatory gene facB of Aspergillus nidulans encodes a Zn(II)2Cys6 transcriptional activatorR B Todd, R L Murphy, H M Martin, et al.
Folia Morphologica|January 21, 2006
The results of compression forces applied to the isolated human calvariaR S Tubbs, R L Murphy, J B Golden, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Safety, pharmacokinetics, and efficacy of (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine with efavirenz and stavudine in antiretroviral-naïve human immunodeficiency virus-infected patientsC Herzmann, K Arastèh, R L Murphy, et al.
Archives of Environmental Health|October 1, 1972
Low exposure to asbestos. Gas exchange in ship pipe coverers and controlsR L Murphy, E A Gaensler, R A Redding, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1989
Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patientsP S Pegram, J P Phair, R McMahan, et al.
Chest|May 1, 1992
Concurrent bacterial lung infection in patients with AIDS, PCP, and respiratory failureW T Peruzzi, B A Shapiro, G A Noskin, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Predictors of outcome in AIDS patients receiving zidovudineJ P Steinberg, J B Spear, R L Murphy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1994
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044J R Black, J Feinberg, R L Murphy, et al.
HIV Medicine|May 26, 2010
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patientsS Lambert-Niclot, N Machouf, G Peytavin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 1999
Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3R B Pollard, D Peterson, D Hardy, et al.
Pageof 11